201 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
202 |
JANSSEN PHARMACEUTIC, et al v. MYLAN PHARMACEUTICAL |
2:03-cv-06220 |
D.N.J. |
|
|
|
|
203 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
204 |
KREMERS URBAN DEVELOPMENT COMPANY et al v. ESTEVE QUIMICA, S.A. et al |
1:03-cv-01684 |
D.D.C. |
|
- 8 Product company
- 9 Individual
|
|
|
205 |
CEPHALON, INC. v. MYLAN PHARMACEUTICAL, et al |
2:03-cv-01394 |
D.N.J. |
|
|
|
|
206 |
Merck & Co., Inc. v. Mylan Pharmaceutical |
1:03-cv-01953 |
S.D.N.Y. |
|
|
|
|
207 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
208 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00213 |
D.Vt. |
|
|
|
|
209 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
210 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
211 |
Ortho-McNeil Pharm., et al v. Mylan Laboratories, et al |
1:02-cv-00032 |
N.D.W.Va. |
|
|
|
|
212 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
213 |
Alza Corporation, et al v. Mylan Laboratories, et al |
2:02-cv-00020 |
D.Vt. |
|
|
|
|
214 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
215 |
ALZA CORPORATION, et al v. MYLAN LABORATORIES, et al |
2:02-cv-00230 |
W.D.Pa. |
|
|
|
|
216 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
217 |
ORGANON INC., et al v. MYLAN PHARMACEUTICAL |
2:01-cv-03835 |
D.N.J. |
|
|
|
|
218 |
Bristol-Myers Squibb v. Mylan Pharmaceut., et al |
1:01-cv-00414 |
S.D.N.Y. |
|
|
|
|
219 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
220 |
ASTRAZENECA UK LTD, et al v. MYLAN PHARMACEUTICAL |
2:00-cv-02239 |
W.D.Pa. |
|
|
|
|
221 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
222 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
223 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
224 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
225 |
AstraZeneca AB, et al v. Mylan Laboratories, et al |
1:00-cv-06749 |
S.D.N.Y. |
|
|
|
|
226 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
227 |
Geneva Pharm., et al v. Mylan Pharmaceutical |
1:00-cv-06449 |
S.D.N.Y. |
|
|
|
|
228 |
SCHERING CORPORATION v. MYLAN PHARMACEUTICAL |
2:00-cv-01657 |
D.N.J. |
|
|
|
|